TABLE 2.
Variables | HR | 95% CI | B-values* | p value** |
---|---|---|---|---|
BCLC stage | <0.001 | |||
B | 1 | |||
C | 5.712 | 3.590–9.087 | 1.742 | |
Maximum tumor size (cm) | <0.001 | |||
≤7 | 1 | |||
>7 | 3.485 | 2.346–5.177 | 1.248 | |
AFP (ng/ml) | 0.001 | |||
≤200 | 1 | |||
>200 | 2.086 | 1.211–4.237 | 0.735 | |
ALBI grade | 0.002 | |||
1 | 1 | |||
2 | 2.024 | 1.296–3.162 | 0.705 | |
No. of lesions | 0.003 | |||
1 | 1 | |||
>1 | 1.744 | 1.208–2.518 | 0.556 | |
Lobes involved | 0.006 | |||
Unilobar | 1 | |||
Bilobar | 2.038 | 1.223–3.396 | 0.712 | |
Age (y) | 0.110 | |||
≤55 | 1 | |||
>55 | 0.689 | 0.437–1.089 | −0.372 |
B-values are regression coefficients.
Univariate logistic regression analysis was used. BCLC, Barcelona Clinic Liver Cancer; AFP, alpha-fetoprotein; ALBI, albumin–bilirubin.